Avinger Inc (AVGR) - Financial and Strategic SWOT Analysis Review

November 2021 | 50 pages | ID: A77EDCD72B84EN
GlobalData

Abstracts

Avinger Inc (AVGR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

• Business description – A detailed description of the company’s operations and business divisions.
• Corporate strategy – Analyst’s summarization of the company’s business strategy.
• SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history – Progression of key events associated with the company.
• Major products and services – A list of major products, services and brands of the company.
• Key competitors – A list of key competitors to the company.
• Key employees – A list of the key executives of the company.
• Executive biographies – A brief summary of the executives’ employment history.
• Key operational heads – A list of personnel heading key departments/functions.
• Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
• Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
• Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Avinger Inc (Avinger) designs, manufactures and sells image-guided, catheter-based systems to treat patients with peripheral artery disease (PAD). It develops products based on its Lumivascular platform, an intravascular image-guided system that provides real-time visualization of the inside of the artery during PAD treatment by using optical coherence tomography (OCT). The company’s product portfolio includes Lightbox imaging console, the Ocelot family of catheters and Pantheris, an image-guided atherectomy device. Avinger sells a suite of products in the US and selected international markets. The company’s products are used by physicians including interventional cardiologists, vascular surgeons, and interventional radiologists to treat patients with PAD. Avinger is headquartered in Redwood City, California, the US.

Avinger Inc Key Recent Developments

Oct 06,2021: Fourth and final round of late-breaking clinical trials announced at VIVA21
May 20,2021: Hydromer selected as key coatings provider for Avinger’s image-guided PAD therapeutic devices
May 06,2021: Avinger reports first quarter 2021 financial results
Mar 11,2021: Avinger Reports Fourth Quarter 2020 Financial Results
Nov 10,2020: Avinger reports third quarter 2020 financial results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

• The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

• The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

• Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.

• Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

• Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Contents

SECTION 1 - ABOUT THE COMPANY

Avinger Inc - Key Facts
Avinger Inc - Key Employees
Avinger Inc - Key Employee Biographies
Avinger Inc - Major Products and Services
Avinger Inc - History
Avinger Inc - Company Statement
Avinger Inc - Locations And Subsidiaries
Head Office

SECTION 2 – COMPANY ANALYSIS

Company Overview
Avinger Inc - Business Description
Avinger Inc - Corporate Strategy
Avinger Inc - SWOT Analysis
SWOT Analysis - Overview
Avinger Inc - Strengths
Avinger Inc - Weaknesses
Avinger Inc - Opportunities
Avinger Inc - Threats
Avinger Inc - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Avinger Inc, Medical Equipment, Deals By Year, 2015 to YTD 2021
Avinger Inc, Medical Equipment, Deals By Type, 2015 to YTD 2021
Avinger Inc, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

Oct 06, 2021: Fourth and final round of late-breaking clinical trials announced at VIVA21
May 20, 2021: Hydromer selected as key coatings provider for Avinger’s image-guided PAD therapeutic devices
May 06, 2021: Avinger reports first quarter 2021 financial results
Mar 11, 2021: Avinger Reports Fourth Quarter 2020 Financial Results
Nov 10, 2020: Avinger reports third quarter 2020 financial results
Nov 05, 2020: Avinger announces commercial launch in Israel
Jul 30, 2020: Avinger reports second quarter 2020 financial results
May 13, 2020: Avinger reports first quarter 2020 financial results
Apr 23, 2020: Avinger receives loan under Paycheck Protection Program
Apr 15, 2020: Avinger reports preliminary first quarter 2020 revenue results

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List Of Tables

LIST OF TABLES

Avinger Inc, Key Facts
Avinger Inc, Key Employees
Avinger Inc, Key Employee Biographies
Avinger Inc, Major Products and Services
Avinger Inc, History
Avinger Inc, Key Competitors
Avinger Inc, Ratios based on current share price
Avinger Inc, Annual Ratios
Avinger Inc, Annual Ratios (Cont...1)
Avinger Inc, Annual Ratios (Cont...2)
Avinger Inc, Interim Ratios
Avinger Inc, Medical Equipment, Deals By Year, 2015 to YTD 2021
Avinger Inc, Medical Equipment, Deals By Type, 2015 to YTD 2021
Avinger Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List Of Figures

LIST OF FIGURES

Avinger Inc, Performance Chart (2016 - 2020)
Avinger Inc, Ratio Charts
Avinger Inc, Medical Equipment, Deals By Year, 2015 to YTD 2021
Avinger Inc, Medical Equipment, Deals by Type, 2015 to YTD 2021